RxDoctor Payments Data

Talhat Azemi, MD

Interventional Cardiology · Hartford, CTNPI 1942407853

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,273 of the $12,051 with a category attached, or 68.6%. Medtronic accounts for 61.8% of it on its own, with 22 other manufacturers making up the rest.

$12,051in general payments, 2019–2025

Across 229 payments — averaging $52.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$7K
  • Abbott$2K
  • Edwards Lifesciences$1K
  • Boston Scientific$295
  • Bard Peripheral Vascular, Inc.$196
  • Cardiovascular Systems Inc.$158
  • plus $749 from 17 others
$55,643in research payments, 2019–2025

Across 20 payments — averaging $2782.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$56K

What the payments were for

  • Travel & lodging$3,77831%
  • Food & beverage$8,27369%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,051 in reported general payments places this provider in the 70th percentile of 73 interventional cardiology providers in Connecticut.

See all interventional cardiology providers in Connecticut

Medicare billing

Part B allowed, 2024
$89,968
Medicare patients
144
Services billed
344

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Hartford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →